Detalles de la búsqueda
1.
Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer.
Immunity
; 55(3): 527-541.e5, 2022 03 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35231421
2.
B cells are associated with survival and immunotherapy response in sarcoma.
Nature
; 577(7791): 556-560, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31942077
3.
Impact of metronomic trabectedin combined with low-dose cyclophosphamide on sarcoma microenvironment and correlation with clinical outcome: results from the TARMIC study.
Mol Cancer
; 23(1): 37, 2024 02 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38374062
4.
Standardized Pathology Screening of Mature Tertiary Lymphoid Structures in Cancers.
Lab Invest
; 103(5): 100063, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36801637
5.
Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial.
Lancet Oncol
; 23(5): 612-624, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35390339
6.
Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors.
Oncologist
; 27(6): 501-511, 2022 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35278076
7.
Pleiotropic Roles of Scavenger Receptors in Circadian Retinal Phagocytosis: A New Function for Lysosomal SR-B2/LIMP-2 at the RPE Cell Surface.
Int J Mol Sci
; 23(7)2022 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35408805
8.
Baseline circulating unswitched memory B cells and B-cell related soluble factors are associated with overall survival in patients with clear cell renal cell carcinoma treated with nivolumab within the NIVOREN GETUG-AFU 26 study.
J Immunother Cancer
; 10(5)2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35640928
9.
Complement C1s and C4d as Prognostic Biomarkers in Renal Cancer: Emergence of Noncanonical Functions of C1s.
Cancer Immunol Res
; 9(8): 891-908, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34039653
10.
Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade.
Clin Cancer Res
; 27(24): 6749-6760, 2021 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34407968
11.
Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression.
Nat Cancer
; 2(8): 794-802, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35118423
12.
Early Hepatic Lesions Display Immature Tertiary Lymphoid Structures and Show Elevated Expression of Immune Inhibitory and Immunosuppressive Molecules.
Clin Cancer Res
; 26(16): 4381-4389, 2020 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32269054
Resultados
1 -
12
de 12
1
Próxima >
>>